Literature DB >> 9209226

Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom.

R F Clark1, S R Williams, S P Nordt, L V Boyer-Hassen.   

Abstract

STUDY
OBJECTIVE: To report the effectiveness of a new polyvalent crotalid antivenom on neurotoxicity associated with North American rattlesnake envenomation. Two syndromes of crotalid-induced neurotoxicity have been reported. In severe envenomation by Crotalus scutulatus scutulatus (Mojave rattlesnake), weakness and fasciculations of various muscle groups, including those innervated by cranial nerves, may develop. Occasionally respiratory insufficiency develops. The second neurotoxic effects is myokymia, a type of fasciculation most frequently reported after bites by Crotalus horridus horridus (timber rattlesnake) and Crotalus atrox (Western diamondback rattlesnake). Conventional polyvalent antivenom is often ineffective in the treatment of venom-induced neurotoxicity.
METHODS: We report a case series of three patients envenomated by North American rattlesnakes, one of which was identified as C scutulatus scutulatus. All three patients experienced neurotoxicity with weakness, paresthesias, and dramatic fasciculations, along with other signs and symptoms of crotalid venom poisoning.
RESULTS: The administration of new polyspecific crotalid antivenom made of ovine Fab was successful in immediately and completely reversing neurotoxicity in each of these patients.
CONCLUSION: We report the use of a new antivenom for North American crotalid envenomation that seems to have efficacy in reversing neurotoxicity associated with these bites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209226     DOI: 10.1016/s0196-0644(97)70111-2

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  7 in total

Review 1.  Antivenom therapy in the Americas.

Authors:  K Heard; G F O'Malley; R C Dart
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

2.  A case of neurotoxicity following envenomation by the Sidewinder rattlesnake, Crotalus cerastes.

Authors:  Adam R Bosak; Anne-Michelle Ruha; Kimberlie A Graeme
Journal:  J Med Toxicol       Date:  2014-06

3.  The binding effectiveness of anti-r-disintegrin polyclonal antibodies against disintegrins and PII and PIII metalloproteases: An immunological survey of type A, B and A+B venoms from Mohave rattlesnakes.

Authors:  Esteban Cantú; Sahiti Mallela; Matthew Nyguen; Raúl Báez; Victoria Parra; Rachel Johnson; Kyle Wilson; Montamas Suntravat; Sara Lucena; Alexis Rodríguez-Acosta; Elda E Sánchez
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2016-10-28       Impact factor: 3.228

4.  Does the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?

Authors:  S R Offerman; T S Smith; R W Derlet
Journal:  West J Med       Date:  2001-08

5.  Crotalidae polyvalent immune Fab: a guide to its use in North American crotaline envenomation.

Authors:  Gillian M Keating; Katherine A Lyseng-Williamson
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

6.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.

Authors:  Eric J Lavonas; Anne-Michelle Ruha; William Banner; Vikhyat Bebarta; Jeffrey N Bernstein; Sean P Bush; William P Kerns; William H Richardson; Steven A Seifert; David A Tanen; Steve C Curry; Richard C Dart
Journal:  BMC Emerg Med       Date:  2011-02-03

Review 7.  Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.

Authors:  Eric J Lavonas; Tammi H Schaeffer; Jamie Kokko; Sara L Mlynarchek; Gregory M Bogdan
Journal:  BMC Emerg Med       Date:  2009-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.